Last reviewed · How we verify

18F-PSMA — Competitive Intelligence Brief

18F-PSMA (18F-PSMA) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PET imaging agent / Radiotracer. Area: Oncology.

phase 2 PET imaging agent / Radiotracer PSMA (Prostate-Specific Membrane Antigen) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

18F-PSMA (18F-PSMA) — Alessandro D'Agnolo. 18F-PSMA is a fluorine-18 labeled radiotracer that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
18F-PSMA TARGET 18F-PSMA Alessandro D'Agnolo phase 2 PET imaging agent / Radiotracer PSMA (Prostate-Specific Membrane Antigen)
C-11 labeled nicotine C-11 labeled nicotine University of Cincinnati marketed PET imaging agent / radiotracer Nicotinic acetylcholine receptors
PET Scan with [11C]ABP688 PET Scan with [11C]ABP688 Stony Brook University marketed PET imaging agent / Radiotracer mGluR5 (metabotropic glutamate receptor 5)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PET imaging agent / Radiotracer class)

  1. Alessandro D'Agnolo · 1 drug in this class
  2. Stony Brook University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 18F-PSMA — Competitive Intelligence Brief. https://druglandscape.com/ci/18f-psma. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: